EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel Insertion in the Hepatitis B Virus Surface Protein Leading to Hyperglycosylation Causes Diagnostic and Immune Escape

Felix Lehmann iD, Heiko Slanina iD, Martin Roderfeld iD, Elke Roeb iD, Jonel Trebicka iD, John Ziebuhr iD, Wolfram H Gerlich, Christian G Schüttler, Bernhard Schlevogt, Dieter Glebe iD

Viruses · 2023

DOI: 10.3390/v15040838 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Felix Lehmann und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Virology, National Reference Center for Hepatitis B Viruses and Hepatitis D Viruses, German Center for Infection Research (DZIF;…. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Hepatitis B. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), German Ministry of Health via the Robert Koch Institute, Berlin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic hepatitis B virus (HBV) infection is a global health threat. Mutations in the surface antigen of HBV (HBsAg) may alter its antigenicity, infectivity, and transmissibility. A patient positive for HBV DNA and detectable but low-level HBsAg in parallel with anti-HBs suggested the presence of immune and/or diagnostic escape variants. To support this hypothesis, serum-derived HBs gene sequences were amplified and cloned for sequencing, which revealed infection with exclusively non-wildtype HBV subgenotype (sgt) D3. Three distinct mutations in the antigenic loop of HBsAg that caused additional N-glycosylation were found in the variant sequences, including a previously undescribed six-nucleotide insertion. Cellular and secreted HBsAg was analyzed for N-glycosylation in Western blot after expression in human hepatoma cells. Secreted HBsAg was also subjected to four widely used, state-of-the-art diagnostic assays, which all failed to detect the hyperglycosylated insertion variant. Additionally, the recognition of mutant HBsAg by vaccine- and natural infection-induced anti-HBs antibodies was severely impaired. Taken together, these data suggest that the novel six-nucleotide insertion as well as two other previously described mutations causing hyperglycosylation in combination with immune escape mutations have a critical impact on in vitro diagnostics and likely increase the risk of breakthrough infection by evasion of vaccine-induced immunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B, ChronicHepatitis BHumansHepatitis B virusHepatitis B Surface AntigensHepatitis B AntibodiesHepatitis B VaccinesMutationImmunologic FactorsNucleotidesMembrane Proteins

Stichwörter der Autor:innen

N-linked glycosylationdiagnostic escapehepatitis B virusimmune escape

Substanzen

Hepatitis B Surface AntigensHepatitis B AntibodiesHepatitis B VaccinesImmunologic FactorsNucleotidesMembrane Proteins

Autor:innen und Institutionen

  • Institute of Medical Virology, National Reference Center for Hepatitis B Viruses and Hepatitis D Viruses, German Center for Infection Research (DZIF; Partner Site Giessen-Marburg-Langen), Justus Liebig University, 35392…
  • Department of Gastroenterology, Justus Liebig University, 35392 Giessen, Germany.
  • Department of Medicine B, University Hospital Muenster, 48149 Muenster, Germany.
  • Department of Gastroenterology, Medical Center Osnabrueck, 49076 Osnabrueck, Germany.

ORCID-Profile: Felix Lehmann, Heiko Slanina, Martin Roderfeld, Elke Roeb, Jonel Trebicka, John Ziebuhr, Dieter Glebe

Förderung

  • Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
  • German Ministry of Health via the Robert Koch Institute, Berlin

Zitieren

APA

Lehmann, F., Slanina, H., Roderfeld, M., Roeb, E., Trebicka, J., Ziebuhr, J., Gerlich, W. H., Schüttler, C. G., Schlevogt, B., & Glebe, D. (2023). A Novel Insertion in the Hepatitis B Virus Surface Protein Leading to Hyperglycosylation Causes Diagnostic and Immune Escape. Viruses. https://doi.org/10.3390/v15040838

Vancouver

Lehmann F, Slanina H, Roderfeld M, Roeb E, Trebicka J, Ziebuhr J, et al. A Novel Insertion in the Hepatitis B Virus Surface Protein Leading to Hyperglycosylation Causes Diagnostic and Immune Escape. Viruses. 2023. doi:10.3390/v15040838

BibTeX
@article{Lehmann2023,
  author = {Lehmann, Felix and Slanina, Heiko and Roderfeld, Martin and Roeb, Elke and Trebicka, Jonel and Ziebuhr, John and Gerlich, Wolfram H and Schüttler, Christian G and Schlevogt, Bernhard and Glebe, Dieter},
  title = {A Novel Insertion in the Hepatitis B Virus Surface Protein Leading to Hyperglycosylation Causes Diagnostic and Immune Escape},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15040838}
}
Kostenlos starten →